Cumberland Pharmaceuticals Files 8-K
Ticker: CPIX · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1087294
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: CPRX
TL;DR
CPRX filed an 8-K for financial updates, check for details.
AI Summary
Cumberland Pharmaceuticals Inc. filed an 8-K on March 4, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the period ending March 4, 2025. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing indicates Cumberland Pharmaceuticals is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific negative or positive financial disclosures, making the immediate risk level low.
Key Players & Entities
- CUMBERLAND PHARMACEUTICALS INC (company) — Registrant
- 0001087294 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- March 4, 2025 (date) — Date of Report
- 2525 West End Avenue, Suite 950 Nashville, Tennessee 37203 (location) — Principal Executive Offices
- 615-255-0068 (phone_number) — Registrant's telephone number
FAQ
What specific financial results are being reported in this 8-K filing?
The provided excerpt states the filing is for 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but does not detail specific financial figures.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is March 4, 2025.
What is Cumberland Pharmaceuticals Inc.'s Standard Industrial Classification code?
The SIC code for Cumberland Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where are Cumberland Pharmaceuticals Inc.'s principal executive offices located?
The principal executive offices are located at 2525 West End Avenue, Suite 950, Nashville, Tennessee 37203.
What is the SEC file number for Cumberland Pharmaceuticals Inc.?
The SEC file number for Cumberland Pharmaceuticals Inc. is 001-33637.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding CUMBERLAND PHARMACEUTICALS INC (CPIX).